Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism

被引：0
|
作者：
Tomasz Hryszko
Szymon Brzosko
Alicja Rydzewska-Rosolowska
Ewa Koc-Zorawska
Michal Mysliwiec
机构：
[1] Medical University of Bialystok,Department of Nephrology and Transplantation
来源：
International Urology and Nephrology | 2012年 / 44卷
关键词：
Bone metabolism; Cinacalcet; FGF-23; Hemodialysis; Secondary hyperparathyroidism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1479 / 1486
页数：7
相关论文
共 43 条
  • [21] Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism
    Tsukamoto, Y
    Hanaoka, M
    Matsuo, T
    Saruta, T
    Nomura, M
    Takahashi, Y
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (03) : 458 - 464
  • [22] Effect of Cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism
    Bergua, Carlos
    Torregrosa, Jose-Vicente
    Fuster, David
    Gutierrez-Dalmau, Alex
    Oppenheimer, Federico
    Campistol, Jose M.
    TRANSPLANTATION, 2008, 86 (03) : 413 - 417
  • [23] Efficacy of Cinacalcet Combined with Calcitriol in Treating Hemodialysis Patients with Secondary Hyperparathyroidism and Its Effect on Calcium and Phosphorus Metabolism
    Fu, Jingyu
    Yang, Hao
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (03): : 530 - 535
  • [24] Influence of Parathyroidectomy on Bone Metabolism and Bone Pain in Patients with Secondary Hyperparathyroidism
    Schneider, Ralph
    Steinmetz, Carolin
    Karakas, Elias
    Bartsch, Detlef K.
    Schlosser, Katja
    EUROPEAN SURGICAL RESEARCH, 2018, 59 (1-2) : 35 - 47
  • [25] Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation
    Barros, Xoana
    Fuster, David
    Paschoalin, Raphael
    Oppenheimer, Federico
    Rubello, Domenico
    Perlaza, Pilar
    Pons, Francesca
    Torregrosa, Jose V.
    ENDOCRINE, 2015, 49 (01) : 267 - 273
  • [26] Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation
    Xoana Barros
    David Fuster
    Raphael Paschoalin
    Federico Oppenheimer
    Domenico Rubello
    Pilar Perlaza
    Francesca Pons
    Jose V. Torregrosa
    Endocrine, 2015, 49 : 267 - 273
  • [27] An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism
    Malluche, H. H.
    Monier-Faugere, M. -C.
    Wang, G.
    Frazao, J. M.
    Charytan, C.
    Coburn, J. W.
    Coyne, D. W.
    Kaplan, M. R.
    Baker, N.
    McCary, L. C.
    Turner, S. A.
    Goodman, W. G.
    CLINICAL NEPHROLOGY, 2008, 69 (04) : 269 - 278
  • [28] Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism
    Kurajoh, M.
    Inaba, M.
    Okuno, S.
    Nagayama, H.
    Yamada, S.
    Imanishi, Y.
    Ishimura, E.
    Shoji, S.
    Yamakawa, T.
    Nishizawa, Y.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 923 - 930
  • [29] Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism
    M. Kurajoh
    M. Inaba
    S. Okuno
    H. Nagayama
    S. Yamada
    Y. Imanishi
    E. Ishimura
    S. Shoji
    T. Yamakawa
    Y. Nishizawa
    Osteoporosis International, 2011, 22 : 923 - 930
  • [30] Interrelationships Between Sclerostin, Secondary Hyperparathyroidism, and Bone Metabolism in Patients on Hemodialysis
    Nakagawa, Yosuke
    Komaba, Hirotaka
    Hamano, Naoto
    Tanaka, Hisae
    Wada, Takehiko
    Ishida, Hiroaki
    Nakamura, Michio
    Takahashi, Hiroo
    Takahashi, Yuichiro
    Hyodo, Toru
    Hida, Miho
    Suga, Takao
    Kakuta, Takatoshi
    Fukagawa, Masafumi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (01) : E95 - E105
12345